Personalize your patients’ healthcare plans
Broad gene panel covers more hereditary cancers
The 98 genes analyzed were carefully selected based on their association with increased risk for developing the most types of hereditary cancers. See full 98 Gene Matrix >>
Knowing your patients’ risk for hereditary cancers will help you customize their cancer screening frequency and health plans. More about CellMax-DNA >>
CLIA certified lab in Sunnyvale, California
Patented, next generation sequencing SMSEQ™ platform has an analytical specificity of ≥99.999%.